Company Filing History:
1 out of 65 
1 out of 3,688 
1 out of 1 Years Active: 2000
Title: The Innovative Contributions of Donald P. Coffey
Introduction
Donald P. Coffey is a notable inventor based in Lutherville, MD (US). He has made significant contributions to the field of medical technology, particularly in the area of prostate cancer research. His innovative methods have the potential to improve patient outcomes and enhance the understanding of cancer progression.
Latest Patents
Donald P. Coffey holds a patent for a method titled "Prediction of prostate cancer progression by analysis of selected biomarkers." This invention provides a method for screening individuals at risk for prostate cancer progression. It evaluates cells from patients who are at risk for recurrence of prostate cancer following surgery. The method utilizes specific Markovian nuclear texture factors, either alone or in combination with other biomarkers, to determine the likelihood of cancer progression or loss of organ confinement. Additionally, it includes methods for predicting the development of fatal metastatic disease through statistical analysis of selected biomarkers. The invention also incorporates a neural network to analyze and interpret cell morphology data, trained with sets of cell data from known progressors and non-progressors.
Career Highlights
Throughout his career, Donald P. Coffey has worked at prestigious institutions, including the University of Tulsa and The Johns Hopkins University. His work has been instrumental in advancing the understanding of prostate cancer and developing innovative screening methods.
Collaborations
Donald P. Coffey has collaborated with notable colleagues, including Robert W. Veltri and Michael P. Bacus. Their combined expertise has contributed to the development of groundbreaking research in cancer diagnostics.
Conclusion
Donald P. Coffey's contributions to prostate cancer research through his innovative patent demonstrate his commitment to improving medical technology. His work has the potential to significantly impact patient care and cancer treatment strategies.